{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-033758","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2026-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.800905+00:00","generated_at":"2026-05-16T05:37:13.040618+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Five directors resign from Quince Therapeutics board effective immediately","bullets":["Directors Rajiv Patni, Luca Benatti, Margi McLoughlin, Una Ryan, and June Bray resigned on Jan 30, 2026.","Resignations were not due to any disagreement with the company on operations, policies, or practices.","CEO Dirk Thye remains as the sole executive officer; no replacements announced.","Company continues under current management; board size reduced from six to one."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-033758","json":"https://secwatch.observer/filing/0001193125-26-033758.json","markdown":"https://secwatch.observer/filing/0001193125-26-033758.md","text":"https://secwatch.observer/filing/0001193125-26-033758.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526033758/0001193125-26-033758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526033758/d52597d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:37:13.040618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}